Literature DB >> 8937338

Paravertebral muscles in disease of the cervical spine.

S B Wharton1, K K Chan, J D Pickard, J R Anderson.   

Abstract

OBJECTIVES: Cervical spine disorders are common in the older population. The paravertebral muscles are essential to the support and stabilisation of the cervical spine but have been little studied. The aim was to determine whether pathological changes develop in these muscles in patients with severe cervical spine disease, which, if present, might contribute to the pathogenesis and symptomatology of their disorder.
METHODS: Open biopsies of superficial and deep paravertebral muscles were obtained during the course of surgical procedures to alleviate cervical myelopathy. Most of these patients had cervical spondylosis or rheumatoid arthritis involving the cervical spine. The biopsies were compared with muscle obtained at necropsy from patients without a history of cervical spine or neuromuscular disorder.
RESULTS: Muscle from both the study and control groups showed a similar range and severity of abnormalities. In several patients, grouped fibre atrophy suggested chronic partial denervation. Most biopsies showed type 1 fibre predominance and selective type 2 fibre atrophy. Ragged red fibres were a frequent finding and electron microscopy disclosed accumulations of mitochondria, a small proportion of which contained rounded, or longitudinally oriented, single osmiophilic inclusions. Fibres containing core-like areas were also frequent. These pathological features were seen with increasing severity and frequency with increasing age.
CONCLUSIONS: The paravertebral cervical muscles develop pathological abnormalities with increasing age with both neurogenic and myopathic features, the pathogenesis of which is probably multifactorial. Such a muscle disorder would be expected to be accompanied by functional impairment which may contribute to the development and symptomatology of cervical spine disease with increasing age.

Entities:  

Mesh:

Year:  1996        PMID: 8937338      PMCID: PMC1074041          DOI: 10.1136/jnnp.61.5.461

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age.

Authors:  M Corral-Debrinski; T Horton; M T Lott; J M Shoffner; M F Beal; D C Wallace
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

2.  The treatment of acute low back pain--bed rest, exercises, or ordinary activity?

Authors:  A Malmivaara; U Häkkinen; T Aro; M L Heinrichs; L Koskenniemi; E Kuosma; S Lappi; R Paloheimo; C Servo; V Vaaranen
Journal:  N Engl J Med       Date:  1995-02-09       Impact factor: 91.245

3.  Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases.

Authors:  A W Linnane; S Marzuki; T Ozawa; M Tanaka
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

4.  Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patients.

Authors:  M Yamamoto; P R Clemens; A G Engel
Journal:  Neurology       Date:  1991-11       Impact factor: 9.910

5.  Morphological analyses of paraspinal muscles: comparison of progressive lumbar kyphosis (camptocormia) and narrowing of lumbar canal by disc protrusions.

Authors:  M B Delisle; M Laroche; H Dupont; P Rochaix; J L Rumeau
Journal:  Neuromuscul Disord       Date:  1993 Sep-Nov       Impact factor: 4.296

Review 6.  Mitochondrial cytopathies.

Authors:  A H Schapira
Journal:  Curr Opin Neurobiol       Date:  1993-10       Impact factor: 6.627

7.  Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy.

Authors:  M H Brooke; G M Fenichel; R C Griggs; J R Mendell; R Moxley; J Florence; W M King; S Pandya; J Robison; J Schierbecker
Journal:  Neurology       Date:  1989-04       Impact factor: 9.910

8.  Mitochondrial DNA deletions in inclusion body myositis.

Authors:  A Oldfors; N G Larsson; C Lindberg; E Holme
Journal:  Brain       Date:  1993-04       Impact factor: 13.501

9.  Randomised controlled trial for evaluation of fitness programme for patients with chronic low back pain.

Authors:  H Frost; J A Klaber Moffett; J S Moser; J C Fairbank
Journal:  BMJ       Date:  1995-01-21

10.  Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: an age-related alteration.

Authors:  J Müller-Höcker
Journal:  J Neurol Sci       Date:  1990-12       Impact factor: 3.181

View more
  6 in total

Review 1.  Dropped head syndrome due to myogenic atrophy - a case report of surgical treatment.

Authors:  Michihisa Zenmyo; Masahiko Abematsu; Takuya Yamamoto; Yasuhiro Ishidou; Setsuro Komiya; Kosei Ijiri
Journal:  Diagn Pathol       Date:  2011-01-19       Impact factor: 2.644

2.  Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson's disease.

Authors:  Arne Wrede; Nils G Margraf; Hans H Goebel; Günther Deuschl; Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

3.  Establishment of cervical dynamic and static imbalance models and preliminary study on the mechanism of cervical degeneration in rats.

Authors:  Haibo Li; Jianjian Yin; Yongjing Huang; Nanwei Xu; Liang Chen; Luming Nong
Journal:  Innate Immun       Date:  2019-08-25       Impact factor: 2.680

4.  Mitochondrial DNA deletions and depletion within paraspinal muscles.

Authors:  G R Campbell; A Reeve; I Ziabreva; T M Polvikoski; R W Taylor; R Reynolds; D M Turnbull; D J Mahad
Journal:  Neuropathol Appl Neurobiol       Date:  2013-06       Impact factor: 8.090

Review 5.  Pathophysiological Concepts and Treatment of Camptocormia.

Authors:  N G Margraf; A Wrede; G Deuschl; W J Schulz-Schaeffer
Journal:  J Parkinsons Dis       Date:  2016-06-16       Impact factor: 5.568

6.  Camptocormia in Parkinson's Disease: A Muscle Disease Due to Dysregulated Proprioceptive Polysynaptic Reflex Arch.

Authors:  Walter J Schulz-Schaeffer
Journal:  Front Aging Neurosci       Date:  2016-06-21       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.